drugset / Press release
ALK-Abelló, ALK-Abelló is initiating a Phase III study with GRAZAX® in the USA
2006-12-11 · ALK-Abelló A/S · original alk.net ↗
ALK-Abelló is initiating a Phase III study of GRAZAX® in the USA with a view to subsequent filing of an application for registration on the North American market.
The release as fetched from its publisher. alk.net ↗